COMSYS Holdings (1721) · FactUpdate to the quarterly amount recorded for infection-related expenses
Recognition of COVID-19-related expenses
First written in FY2021-Q1. . Latest entry: FY2024-Q1.
9entries
4years
0from disclosures
How it moved
Same theme, other companies
Recognition of losses related to COVID-19A theme 12 companies write about · 12 as a headwind · 0 as a tailwind
4 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024-Q1Update to the quarterly amount recorded for infection-related expensesAnnual report
「Expenses related to COVID-19 26 28」
COVID-19-related expenses totalled ¥28 million for the cumulative first quarter, up from ¥26 million in the same period of the previous year. - FY2023-Q3Decrease in infection-related expensesAnnual report
「Expenses related to COVID-19 122 89」
COVID-19-related expenses totalled ¥89 million for the nine months ended the third quarter, down from ¥122 million in the same period of the previous year. - FY2023-Q2Decrease in infection-related expensesAnnual report
「Expenses related to COVID-19 82 63」
COVID-19-related expenses totalled ¥63 million for the six months ended the second quarter, down from ¥82 million in the same period of the previous year. - FY2023-Q1Update to the quarterly amount recorded for infection-related expensesAnnual report
「Expenses related to COVID-19 26 28」
COVID-19-related expenses totalled ¥28 million for the cumulative first quarter, up from ¥26 million in the same period of the previous year. - FY2022-Q3Decrease in infection-related expensesAnnual report
「Expenses related to COVID-19 261 122」
COVID-19-related expenses totalled ¥122 million for the nine months ended the third quarter, down from ¥261 million in the same period of the previous year. - FY2021Full-year recognition of infection-related expensesAnnual report
「Expenses related to COVID-19 285」
The company recorded ¥285 million in COVID-19-related expenses as non-operating expenses for the full year. - FY2021-Q3Increase in infection-related expensesAnnual report
「Expenses related to COVID-19 — 261」
The company recorded ¥261 million in COVID-19-related expenses as non-operating expenses for the nine months ended the third quarter. - FY2021-Q2Increase in infection-related expensesAnnual report
「Expenses related to COVID-19 — 192」
The company recorded ¥192 million in COVID-19-related expenses for the six months ended the second quarter, an increase from none recorded in the same period of the previous year. - FY2021-Q1First statedAnnual report
「Expenses related to COVID-19 — 87」
The company recorded ¥87 million in COVID-19-related expenses as non-operating expenses in the first quarter under review.